M
Metagenics
Metagenics | Better Health Through Nutrition & Lifestyle Medicine
About Metagenics
In 1983, the Katke brothers—specifically Jeff and Mike Katke—founded Metagenics in California. The company was built on a simple premise that was ahead of its time: that diet, lifestyle, and nutrition could influence how a person's genes express themselves. They bypassed the crowded consumer supplement aisle, focusing instead on a practitioner channel. They sold their science-backed nutritional formulas and medical foods directly to doctors, chiropractors, and other healthcare professionals who would then recommend them to patients. This strategy of focusing on the practitioner channel proved to be a key decision. It allowed the company to build a trusted brand based on scientific validation and quality, differentiating it from competitors who were seen more as marketing companies. This model fueled steady growth, establishing Metagenics as a leader in its niche. A significant event in the company's journey occurred in 2009 when Alticor, the parent company of Amway, acquired a majority stake in Metagenics. This move provided an opportunity for expansion and for some early shareholders to cash out. The story continued with another major transition in late 2021, when private equity firm Gryphon Investors acquired Metagenics from Alticor, aiming to support the brand's long-term global growth.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1983
- Headquarters
- Aliso Viejo, United States
- Employees
- 1,090
- Open positions
- 24
- Dealroom signal
- 78.9/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Lifestyle, Biotechnology, Nutrition, B Corp
- Client focus
- b2c
- Investment activity
- 2 companies, latest Jan 2026
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| BUYOUT✓Exit | Oct 2021 | $0 | — | Gryphon Investors | — |
| LATE VC✓Equity / VC | Sep 2009 | $28M | $112M | Undisclosed | — |
Growth signals
Latest recorded traffic for Metagenics is 330K monthly website visits, up 135.7% over the last three months. Metagenics's team grew 55.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
SymproveGuildford, United KingdomWater-based probiotic supplement for gut health maintenance
→
NutriMilton Keynes, United KingdomNutri Advanced | Vitamins, Health & Nutritional Supplements
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Bison Capital Asset Management
Series B and later1 investor entered at this stage
Gryphon Investors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Metagenics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Metagenics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







